QA: Harrow INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001360214_2017_Harrow_INC.pdf

Logs

Graph

Absolute values for 0001360214, Harrow INC

  xvar xval
0 AssetsCurrent 14,753,000
1 IntangibleAssetsNetIncludingGoodwill 5,199,000
2 PropertyPlantAndEquipmentNet 7,295,000
3 remainder_Assets 0
4 LiabilitiesCurrent 9,905,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 10,910,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 26,894,680
9 ResearchAndDevelopmentExpense 2,449,704
10 remainder_Expenses 38,759,950
11 remainder_Revenues 71,029,044
12 remainder_NetIncome -3,258,539
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 27,247,000
1 Liabilities 20,815,000
2 Expenses 68,104,334
3 Revenues 71,029,044
4 StockholdersEquity 6,432,000
5 NetIncome -333,829
6 ComprehensiveNetIncome -333,829
7 BaseVar 95,226,958
8 EconomicCapitalRatiobeforeLimitedLiability 0.570
9 EconomicCapitalRatio 1.94

Edgar->Model Mapping

Feature Distribution

Change over Time